Related Experiment Videos
Secondary treatment of advanced cancer of the prostate with Zoladex
P Klarskov1, F Lund, S E Petersen
1Department of Urology, Herlev Hospital, Denmark.
International Urology and Nephrology
|January 1, 1990
Abstract:
Twelve patients with advanced prostatic carcinoma and relapse following previous hormone manipulation therapy were treated with Zoladex-depot every 4 weeks. The treatment was well tolerated and the endocrine response was satisfactory. However, no clinically important improvement was obtained.